NRx Pharmaceuticals Announces Submission of an Investigational New Drug (IND) Application for NRX-101 in the Treatment of Chronic Pain ...Middle East

IND builds on previously-published, preliminary evidence of efficacy Filing is supported by robust manufacturing, pre-clinical and clinical data already reviewed by FDA for NRX-101 associated with treatment of bipolar depression RADNOR, Pa., Aug. 30, 2023 /PRNewswire/ - NRx...

Hence then, the article about nrx pharmaceuticals announces submission of an investigational new drug ind application for nrx 101 in the treatment of chronic pain was published today ( Wednesday 30/08/2023 - 01:52 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( NRx Pharmaceuticals Announces Submission of an Investigational New Drug (IND) Application for NRX-101 in the Treatment of Chronic Pain )

Also on site :

• Palestinian Mujahideen Movement Condemns Israeli Enemy& 039;s Prevention of International Organizations from Continuing Their Work
• Lukashenko claims he warned Putin about assassination attempt
• Rose Parade 2026 awards announced: Top honor goes to Cal Poly Universities